福泰制药 VRTX 深 沪
交易中 03-25 11:44:54 美东时间
457.64
+9.020
+2.01%
华盛通- 最 高457.75
- 今 开449.14
- 成交量 31.44万股
- 最 低 449.14
- 昨 收 448.62
- 总市值 1162.56亿
- 52周最高 510.77
- 市盈率 静 29.87
- 换手率 0.12%
- 52周最低 362.50
- 委 比 99.23%
- 总股本 2.54亿
- 历史最高 519.88
- 量 比 0.71
- 振 幅 1.92%
- 历史最低 26.50
- 每 手 1
- 风险率 33.74%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Revolution, Ascendis, Arrowhead among RBC’s top M&A candidates in biotech
RBC Capital Markets has compiled a list of 13 biotechs that are most likely to receive takeover interest, including Revolution Medicines (RVMD), Ascendis Pharma (ASND), and Arrowhead Pharma (ARWR), am...
03-20 02:37
美股大行评级 | 超多下调！露露乐蒙、Oklo、腾讯音乐、Docusign、BOBS、Bicycle、Academy Sports等遭多家大行下调目标价
今日重点评级关注：花旗：维持Candel Therapeutics"买入"评级，目标价从22美元升至26美元；Chardan Capital：维持CervoMed"买入"评级，目标价从15美元升至21美元
03-19 14:31
Maxim Group Upgrades Vertex Pharmaceuticals to Buy, Announces $575 Price Target
Maxim Group analyst Naz Rahman upgrades Vertex Pharmaceuticals (NASDAQ:VRTX) from Hold to Buy and announces $575 price target.
03-19 02:48
BUZZ-Vertex rises after brokerage upgrade on kidney disease drug data
BUZZ-Vertex rises after brokerage upgrade on kidney disease drug data ** Shares of drugmaker Vertex Pharmaceuticals VRTX.O rise 1.1% to $463.96 premarket ** Brokerage Maxim Group upgrades Vertex to 'buy' from 'hold'; raises price target to $575 from no prior target, citing positive povetacicept data
03-18 21:13
美股大行评级 | 甲骨文绩后分歧大！小摩上调评级至"超配"，目标价缺降至210美元；科尔士百货、AVAV、Blend Labs、Domo遭多家大行下调评级
今日重点评级关注：LUCID CAPITAL MARKETS：上调INmune Bio评级至"买入" 目标价从2美元升至9美元；Clear Street：维持MoonLake Immunotherapeutics Class A"买入"评级，目标价从45美元升至70美元
03-12 12:34
美股机会日报 | 伊朗国家媒体：英伟达、谷歌等美国巨头或成打击目标！美国2月通胀数据将于20:30公布
伊朗国家媒体：英伟达、谷歌等美国巨头或成打击目标！美国2月通胀数据将于20:30公布，市场预计趋于平稳；甲骨文盘前涨超9%，上季业绩大超预期>>
03-11 20:16
美股大行评级 | 潜在涨幅467.73%！Corbus制药控股获Oppenheimer升目标价至57美元，维持"跑赢大市"评级
今日重点评级关注：Oppenheimer：维持Corbus制药控股"跑赢大市"评级，目标价从53美元升至57美元；Canaccord Genuity：维持WAVE Life Sciences"买入"评级，目标价从43美元升至52美元
03-11 12:40
Oil Crashes 10%, Stocks Rebound On Trump End-Of-War Signals: What's Moving Markets Tuesday?
U.S. stocks rose broadly on Tuesday as crude oil plunges over 10% on Trump's Iran end-of-war signals. Traders also await Oracle's earnings.
03-11 01:03
What's Going On With CRISPR Therapeutics Stock Today?
CRISPR Therapeutics fell Tuesday after unveiling a $350 million convertible notes offering, overshadowing recent momentum from Casgevy uptake and fourth-quarter revenue growth.
03-11 00:56
道指开盘跌0.05%，标普500跌0.03%，纳指涨0.2%
柯尔百货跌2.1%，“性价比”保卫战全面溃败！圣诞季同店销售跌幅超预期。高通跌2.2%，美银给予其“跑输大盘”评级。BioNTech跌18.3%，2026年收入...
03-10 21:30
